Growth hormone (GH) supplementation can increase the body weight of old rats, but the individual tissues affected were previously unidentified. Therefore, the masses of the heart, spleen, kidney, epididymal fat pads, and five skeletal muscles were assessed in male Fischer 3441 Brown Norway rats (9, 20, 31 months) injected with recombinant human GH (0.7 mglkg) or vehicle twice daily for 10 days. Muscle composition (fiber type, protein concentration, dry weight/ wet weight ratio, citrate synthase activity) was also evaluated. Muscle mass was increased with GH treatment, and this increment was undiminished in old age. Fiber type, protein concentration, and dry weight/wet weight ratio were unaffected by GH. Citrate synthase activity declined in the plantaris and increased in the soleus with GH treatment. GH supplementation elevated heart and spleen mass, but not fat pad or kidney weight. The data demonstrate that the capacity for GH-induced hypertrophy of skeletal muscle, myocardium, and spleen is retained during old age.
T HE age-related loss of skeletal muscle mass has important functional implications. Consequently, there is much interest in identifying interventions that can attenuate or reverse muscle atrophy in older individuals. Growth hormone (GH) can be a potent stimulus for muscle growth in young animals, so considerable attention has been devoted to the possible influence of GH supplementation in the elderly. Nonetheless, apparently only two published studies have directly assessed the efficacy of GH for promoting hypertrophy of individual muscles from older (26-27 months) rats (Ullman et al., 1990; Carmeli et al., 1993) . Ullman and colleagues reported that body weight was increased by 13% in old GH-treated rats, despite no increase in the mass of the extensor digitorum longus (EDL) muscle, indicating that GH treatment must have induced an increase in the mass of other muscles or nonmuscle tissue. Carmeli et al. (1993) observed no increase in body weight or gastrocnemius plus plantaris mass in older GH-treated rats. Each of these earlier studies only examined one or two muscles and no nonmuscle tissues from rats at a single age (i.e., 26-27 months), so they provide an incomplete view of the influence of age on responsiveness to GH.
Therefore, the primary purpose of this study was to characterize the influence of GH supplementation on the mass of several skeletal muscles (i.e., gastrocnemius, plantaris, soleus, extensor digitorum longus, and brachioradialis) in male Fischer 344/Brown Norway rats at a wide range of ages during adulthood (9, 20, and 31 months old). We also evaluated several aspects of skeletal muscle composition (i.e., fiber type, protein concentration, dry weight/wet weight ratio, and citrate synthase activity) and determined the impact of GH administration on the mass of other tissues that are responsive to GH treatment during youth (i.e., heart, spleen, kidney, adipose tissue).
METHODS

Treatment of rats. -Male Fischer 344/Brown Norway
Fl hybrid (F344/BN) rats of three ages (8-9, 19-20, or 30-31 months) were obtained from Charles River Breeding Laboratories. The age groups will be hereafter referred to as the 9-, 20-, or 31-month-old groups. Upon arriving at Madison, rats were housed in a facility isolated from contact with other animals, and their caretakers did not come into contact with any other rodents. The animal room was maintained at 23-24°C, with a relative humidity of 54-55% and a light-on/light-off schedule of 6 a.m./6 p.m. Rats were provided with N1H-31M rodent diet (Agway Inc., Syracuse) and water ad libitum until 4 p.m. on the day before they were killed, when they were limited to 5 g of food. After equilibrating with their new environment for 10-20 days, rats were randomly assigned to vehicle control or GH-treated groups (before GH supplementation, body weights of agematched control and treated groups were not significantly different). The rats received subcutaneous injections twice daily, at 8 a.m. and at 3 p.m., for 10 consecutive days. The GH group was injected with recombinant-derived human GH (rhGH; Genentech, South San Francisco, CA; 0.7 mg/ kg body weight per injection) dissolved in sterile water containing 0.9% benzyl alcohol (Abbott Laboratories, Chicago); the vehicle control group was injected with an equivalent volume of sterile water. Body weight was determined on the day after the last injection when the rats were killed. Food intake during the experimental period was evaluated by measuring the food provided to the rats during the first 9 days of treatment (i.e., not including the final day where food intake was restricted) and subtracting the amount of food not eaten. On the day following the last GH injection, animals were anesthetized with pentobarbital sodium (60 mg/kg).
Several skeletal muscles (gastrocnemius, soleus, plantaris, extensor digitorum longus, and brachioradialis), as well as the heart, kidney, spleen, and epididymal fat pads, were dissected out and weighed.
Determination of muscle protein concentration. -Portions of the gastrocnemius and soleus muscles were homogenized in ice-cold buffer containing 20 mM Hepes, 1 mM EDTA, 250 mM sucrose (pH 7.4) at a 1:19 (wt:vol) ratio using a Kontes Duall glass-glass tissue grinder. Protein concentration in the homogenates was determined using the spectrophotometric bicinchoninic assay (Smith et al., 1985) .
Determination of fiber type composition. -After dissection and weighing, soleus and plantaris muscles that were used for histochemistry were mounted on wooden holders, frozen in isopentane cooled to the temperature of liquid N 2 , and stored at -80°C until processed and analyzed. Transverse sections (8 |xm) were taken from the mid-belly of the muscles using a cryostat microtome maintained at-20°C. To distinguish type I, Ila, and lib fibers, serial sections were mounted on coverslips and stained for myosin ATPase after preincubation at pH 10.4, 4.54, or 4.50, respectively. Stained sections were projected using a Bausch and Lomb microprojector, and >1000 fibers were classified for each muscle as previously described (Brooke and Kaiser, 1970) .
Determination of muscle citrate synthase activity. -Portions of the soleus and plantaris muscles were homogenized. Homogenates were analyzed for citrate synthase (CS) activity at 30°C using a DU-6 UV-Visible Spectrophotometer (Beckman Instruments) (Srere, 1969) .
Determination of tissue dry weight. -Portions of the gastrocnemius and soleus muscles were weighed and then dried in an oven. The muscles were then weighed on consecutive days until a stable weight was obtained (i.e., dry weight). Dry weight was also determined for the heart, spleen, and kidney.
Statistical analysis. -The data were analyzed using twoway analysis of variance employing the General Linear Models Procedure (SAS; Cary, NC).
RESULTS
Body weight and food intake. -As previously reported (Cartee and Bohn, 1995) , body weight (g) became progressively greater with advancing age (p < .0001), and GH treatment led to a significant (/; < .0002) elevation in body weight (432.5 ± 4.6 vs 463.3 ± 4.9, 9-month-old; 515.1 ± 6.2 vs 545.8 ± 9 . 1 , 20-month-old; 552.8 vs 578.7 ± 12.5, 31-month-old). The relative GH-induced increase in body weight was 7%, 6%, and 5% in the 9-, 20-, and 31-month-old rats, respectively. Food intake (g) was not significantly affected by age or GH treatment (control vs GH: 21.9 ± 1.0vs22.2 ± 0.6, 9-month-old; 20.6 ± 0.7 vs 20.8 ± 1.0, 20-month-old; 24.3 ± 1.5 vs 20.8 ± 0.6, 31-month-old).
Muscle weight and protein concentration. -A significant effect of age was found on the weight of every muscle studied ( Table 1 ). The relative age-related decrease in the weight (31-month-old control vs apparent peak mass at 9-or 20-month-old controls) varied among the skeletal muscles: gastrocnemius (25%), plantaris (22%), soleus (13%), EDL (15%), and brachioradialis (10%). Treatment with GH led to a significant increase in the weight of each muscle compared to vehicle-treated controls. With the exception of the brachioradialis muscle, the magnitude of the increment above agematched control values tended to be greatest in the oldest rats. Gastrocnemius and soleus protein concentration (Table  2) was not significantly affected by age or GH treatment.
Tissue weights and wet Idry weight ratios. -The wet weights of the spleen, heart, kidney, and epididymal fat pad each increased significantly Q? < .0001) with advancing age (Table 3) . Treatment with GH significantly increased spleen {p < .0001) and heart {p < .005) wet weight in each age group, compared to vehicle-treated controls, by 15-28% and 6-8%, respectively. The kidney and epididymal fat pad weights from the GH-treated groups did not differ from agematched control groups. There were no significant effects of age or GH treatment on the dry weight/wet weight ratios for the gastrocnemius, soleus, heart, or kidney, demonstrating the hypertrophy was not attributable to edema (Table 4) . The GH-treated groups were characterized by a statistically significant {p < .05) decrease in dry weight/wet weight ratio for the spleen, but the magnitude of this decrement (<5%) was quite small compared to the relative increase in spleen wet weight (15-28%).
Muscle fiber type composition. -There was no significant effect of age or GH treatment on the fiber type composition of the soleus (Table 5 ). In the plantaris, a significant 
Notes:
Values (means ± SE) are expressed as the dry weight (mg) -r wet weight (mg); n = 3 -1 0 per group, n.s. = nonsignificant (p > .05).
age-related increase (/; < .005) in the percentage of type I libers occurred, and this effect was not reversed by GH treatment.
Muscle citrate synthase (CS) activity. -There was a significant main effect of age (p < .002) on soleus CS activity, but no significant age effect was evident for the CS of the plantaris muscle (Table 6 ). GH treatment led to a significant {]-> < .01) decline in plantaris CS activity, and a significant (p < .01) increase in soleus CS activity.
DISCUSSION
The magnitude of the effect of GH on skeletal muscle mass was undiminished in old age. In the oldest group, GH treatment led to a 10-13% increase in weight of every muscle studied; in the middle-aged group, GH treatment led to a 3-13% increase; in the youngest group, only the brachioradialis (12% increase) had an increase of >5%. Muscle protein concentration and dry weight/wet weight ratio were stable with GH supplementation, demonstrating that the increase in muscle mass was not attributable to tissue edema. In addition, we recently reported that GH treatment did not alter the distribution of muscle water between the extracellular and intracellular compartments as determined by mannitol space (Cartee and Bonn, 1995) . The GH-induced increase in muscle mass in old rats, along with no decrement in protein concentration or dry weight/wet weight ratio, is consistent with the observation that 8 days of GH supplementation significantly enhances the rate of protein synthesis in skeletal muscle from old male rats (Sonntag et al., 1985) . Assuming that the remainder of the musculature responded in a fashion similar to the muscles that we studied, skeletal muscle would account for a substantial portion of the GHinduced body weight gain.
Two earlier studies reported no effect of rhGH on muscle mass of older female rats. Ullman and coworkers (1990) found no increase in EDL mass of 26-month-old female Sprague-Dawley rats treated with rhGH (4 IU injected daily for 10 weeks). Carmeli et al. (1993) observed no rhGHinduced (0.6 mg/kg, subcutaneously injected on alternate days for 3 weeks) change in muscle (gastrocnemius and plantaris) or body weight of 26-month-old female Wistar rats. Carmeli and colleagues did find that GH administration attenuated the muscle weight loss in immobilized (casted) hindlimb muscles of the old rats. The absence of young controls undergoing identical GH supplementation in each 
Notes:
Values (means ± SE) expressed as (xmol # min" u g"'; // = 6-10 rats per group, n.s. nonsignificant (/; > .05).
of the earlier studies prevents an unambiguous evaluation of the influence of age on GH-induced changes in muscle mass. However, in an earlier study, Ullman and Oldfors (1989) reported a 24% increase in the EDL weight of 5-month-old female Sprague-Dawley rats injected with rhGH (4 IU daily for 36 days). Unlike our results, these previously published findings suggested that, with advancing age, skeletal muscle becomes resistant to the growth promoting effects of GH. The explanation for the absence of a GH effect on the muscle mass of older rats in earlier studies is uncertain. Gender might be a factor because female rats were used in the two studies that did not find a GH-induced increase in muscle mass during old age, whereas we studied males. Other differences in the studies (e.g., rat strain and age; duration, frequency, or dose of the GH injections) might also be important. The experiments failing to observe GHinduced muscle hypertrophy in older rats used a single daily injection or a single injection on alternate days. GH is normally secreted in a pulsatile fashion, and greater growth has been repotted with two to four daily injections compared to a single daily injection (Jansson et al., 1982) . For this reason, the rats in this study were injected twice daily, in the morning and the afternoon. It is notable that Sonntag et al. (1985) studied male rats injected twice daily with GH when they documented a GH-induced enhancement in muscle protein synthesis during old age.
Previously, we reported that the serum insulin-like growth factor-I (IGF-I) concentration did not change with age in control animals used for this study (controls: 9-month = 4.24; 20-month = 4.40; 31-month = 4 .25 U/ml), and IGF-I levels were approximately doubled by GH supplementation at every age (GH: 9-month = 9.73; 20-month = 9.52; 31-month = 8.98 U/ml) (Cartee and Bohn, 1995) . Since skeletal muscle expresses receptors for both GH and IGF-I, muscle hypertrophy could potentially be directly mediated by GH or indirectly mediated by IGF-I. However, Guler et al. (1988) demonstrated that infusion of rhIGF-I does not stimulate muscle growth in hypophysectomized rats, suggesting that the hypertrophy depends on the presence of GH.
Although aging has repeatedly been shown not to alter the fiber type composition of the soleus or EDL (Eddingeret al., 1985; Florini and Ewton, 1989; Brown et al., 1992) , Holloszy et al. (1991) found that the percentage of type I fibers of the plantaris was higher in 28-to 30-month-old rats compared to 9-month-old Long Evans rats. Consistent with these earlier investigations, we observed no effect of age on soleus fiber type composition and a significant age-related increase in the percentage of type I fibers of the plantaris. Also, in agreement with the findings of Florini and Ewton (1989) , the fiber type composition of the soleus was unaffected by GH administration. Furthermore, GH supplementation did not reverse the age-related increase in type I fibers found in the plantaris. This lack of difference in fiber type composition, as we determined using the myosin ATPase technique (Brooke and Kaiser, 1970) , does not eliminate the possibility that fibers contain more than one isoform of myosin heavy chain.
Skeletal muscle CS activity has been found to decline with advancing age in various skeletal muscles from F344 (Cartee and Farrar, 1987) , Long Evans (Holloszy et al., 1991) , and Wistar (Hansford and Castro, 1982) rats. Similarly, in the F344/BN rats from this study, soleus CS activity was ~ 17% lower in the 31-month-old group compared to the 9-and 20-month-old control groups. However, plantaris CS activity was not significantly affected by age in F344/BN rats.
Few studies have evaluated the influence of GH on the activity of mitochondrial enzymes in skeletal muscle. Administration of rhGH (556 fxg/day by osmotic minipumps for 10 days) to male Sprague-Dawley rats (35 days old) did not affect succinate dehydrogenase activity of the soleus (Jiang et al., 1993) ; this protocol also did not influence soleus mass. Unexpectedly, the GH supplementation elicited divergent effects on the CS activity in the two muscles that we studied: an increase was observed for the soleus and a decline occurred in the plantaris. Although the explanation for these findings is uncertain, it is apparent that GH treatment can alter the metabolic profile of muscles, even when fiber type composition and total protein concentration are unaffected. Along these lines, we recently reported that GH treatment regimen used in this study can reduce the glucose transport activity of skeletal muscle (Cartee and Bohn, 1995) .
The growth-promoting influence of GH supplementation varied among the tissues studied. Spleen mass of the GHtreated rats was 15-28% higher than the values for agematched controls, greatly exceeding the relative elevation in body weight (5-7%). This observation is consistent with earlier results in younger rats (Ullman and Oldfors, 1989) . GH treatment led to an increase (6-9%) in myocardial mass compared to control values, and the magnitude of the increase that was roughly proportional to the effect on body weight. Comparable observations have been reported for younger rats (Ullman and Oldfors, 1989; Rubin et al., 1990) . Kidney weight was unaltered in the GH-supplemented groups, a finding that differs from published data for young rats: kidney weight has been reported to increase roughly in proportion to the increases for body weight and heart weight (Greenbaum and Young, 1953; Ullman and Oldfors, 1989) . IGF-I, independent of GH, can promote hypertrophy of the spleen, heart, and kidney of young rats (Clark et al., 1985; Guleret al., 1988) . As described above, the circulating IGF-I levels were substantially elevated in the animals from the current study. In this light, the failure for GH to promote renal hypertrophy might be indicative of a tissue-specific resistance to IGF-1 action compared to the younger animals from earlier studies.
GH can stimulate lipolysis (Hart et al., 1984) and reduce body fat stores in young rats (Batchelor and Stern, 1973; Crist et al., 1988) , so it seemed possible that a GH-induced decline might occur in the mass of the epididymal fat pad. Although there was a trend for reduced epididymal fat pad weight in the older animals, there was no significant GH effect. It remains possible that the mass of other fat depots was reduced by GH supplementation.
In younger animals, the growth-promoting action of GH can occur independent of altered food intake, indicating that the weight gain is caused by increased feed efficiency; high doses of exogenous GH can stimulate hyperphagia concomitant with even greater weight gain (Byatt et al., 1993) . In this study, the increased body weight in the GHtreated rats occurred without any change in food intake, regardless of age.
In conclusion, we have identified several of the individual tissues (i.e., skeletal muscle, heart, and spleen) that contribute to the increased body weight in adult, middle-aged, and old male F344/BN rats after a brief period of GH administration. GH supplementation led to an increase in the mass of the skeletal muscles studied, and the magnitude of this increment was unattenuated by advancing age. The results suggest that an increase in skeletal muscle mass accounted for a large portion of the greater body weight in the GHtreated rats.
